<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111786">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01648647</url>
  </required_header>
  <id_info>
    <org_study_id>GE DHM-AN-OR-2012/01</org_study_id>
    <nct_id>NCT01648647</nct_id>
  </id_info>
  <brief_title>Copeptin in Aortic Valve Replacement</brief_title>
  <acronym>CARE</acronym>
  <official_title>GE DHM-AN-OR-2012/01</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Deutsches Herzzentrum Muenchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Deutsches Herzzentrum Muenchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Copeptin is accepted as a marker of stress. We want to evaluate the preoperative and early
      postoperative copeptin leavens in patients undergoing different aortic valve procedures
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Copeptin in Patients Undergoing Aortic Valve Replacement</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for surgical or transcatheter aortic valve replacement
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing surgical aortic valve replacment

          -  Patients undergoing transcatheter aortic valve replacment

        Exclusion Criteria:

          -  denial by patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>D80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <lastchanged_date>July 20, 2012</lastchanged_date>
  <firstreceived_date>July 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
